Lohse M J, Lenschow V, Schwabe U
Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):69-74. doi: 10.1007/BF00518781.
The effects of barbiturates on radioligand binding to inhibitory Ri adenosine receptors of rat brain membranes were investigated. Binding of the adenosine receptor agonist (-)N6-phenylisopropyl[3H]adenosine and the antagonist 1,3-diethyl-8-[3H]phenylxanthine was inhibited by several barbiturates. This inhibition was concentration-dependent and occurred in the range of pharmacologically effective concentrations. Pentobarbital was the most potent of the barbiturates tested with a Ki of 92 mumol/l. The (+)isomers of hexobarbital and mephobarbital were more potent than the respective (-)isomers. Barbituric acid itself did not displace either radioligand in concentrations up to 1 mmol/l. The inhibitory effect of pentobarbital was reversed by a single wash of membranes preincubated with the barbiturate. The presence of pentobarbital caused a decrease of the affinity of the receptor for the antagonist radioligand but did not alter the number of binding sites, suggesting a competitive antagonism. The effects of pentobarbital on radioligand binding to the receptor were not changed by the presence of picrotoxinin nor by the absence of chloride ions. This indicates that they are not mediated via the picrotoxinin binding site. The barbiturates could not be classified as either agonists or antagonists at the Ri adenosine receptor. The presence of GTP did not influence the inhibition of radioligand binding by pentobarbital; this is also observed for antagonists, whereas the affinity of agonists is markedly reduced by GTP. Binding of antagonists to the receptor is enthalpy-driven; the interaction of pentobarbital with the receptor was entropy-driven and the same was true for agonists.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了巴比妥类药物对放射性配体与大鼠脑膜抑制性 Ri 腺苷受体结合的影响。几种巴比妥类药物抑制了腺苷受体激动剂(-)N6-苯异丙基[3H]腺苷和拮抗剂 1,3-二乙基-8-[3H]苯基黄嘌呤的结合。这种抑制作用呈浓度依赖性,且发生在药理有效浓度范围内。戊巴比妥是所测试的巴比妥类药物中最有效的,其 Ki 为 92 μmol/l。己巴比妥和甲丙氨酯的(+)异构体比各自的(-)异构体更有效。巴比妥酸本身在浓度高达 1 mmol/l 时不会取代任何一种放射性配体。用巴比妥酸盐预孵育的膜经单次洗涤后,戊巴比妥的抑制作用可逆转。戊巴比妥的存在导致受体对拮抗剂放射性配体的亲和力降低,但不改变结合位点的数量,提示存在竞争性拮抗作用。戊巴比妥对放射性配体与受体结合的影响不受苦味毒存在与否或氯离子缺失的影响。这表明它们不是通过苦味毒结合位点介导的。巴比妥类药物在 Ri 腺苷受体上既不能归类为激动剂也不能归类为拮抗剂。GTP 的存在不影响戊巴比妥对放射性配体结合的抑制作用;拮抗剂也观察到这种情况,而激动剂的亲和力会被 GTP 显著降低。拮抗剂与受体的结合是由焓驱动的;戊巴比妥与受体的相互作用是由熵驱动的,激动剂也是如此。(摘要截短至 250 字)